Related Articles
Lack of Bcl10 mutations in malignant cartilaginous tumors
HER-2/neu gene amplification by fluorescence in situ hybridization allows risk-group assessment in node-negative breast cancer.
Overexpression of p53 and rare genetic mutation in mesenchymal chondrosarcoma.
Quantitative assessment of HER2/neu expression by real-time PCR and fluorescent in situ hybridization analysis in low-grade osteosarcoma
Rb-loss is associated with high malignancy in chondrosarcoma